The global minimally
invasive thoracic surgery market is expected to reach USD 5.3
billion by 2025, based on a new report by Grand View Research, Inc. Minimally
Invasive Surgery (MIS) is gaining popularity owing to the reduced risk and
trauma associated with these procedures as small incisions decrease post-operative
pain that facilitates a speedy recovery. Increasing research and development in
this field is another high impact rendering driver of the market.
Introduction of novel technologies and devices by the
market players have been observed in the recent years. In 2016, Cardiac
received the FDA clearance for its MicroCutter XCHANGE 30 surgical stapling
device for resection and transection in minimally invasive and open pediatric,
urologic and thoracic surgical procedures.
In the U.S., lung cancer is a second leading cancer
form. According to the American Cancer Society, about 222,500 new lung cancer
cases are estimated in 2017. A high number of smokers in the U.S. is a leading
cause of cancer prevalence in the region.
Smoking is also one of the major risk factors for lung
cancer in developing countries. Nearly 80% of the smokers live in middle and
low-income countries. This makes developing countries a potential market for
thoracic surgeries.
Browse full research report on Minimally Invasive Thoracic Surgery Market: https://www.grandviewresearch.com/industry-analysis/minimally-invasive-thoracic-surgery-market
Further
Key Findings from the Study Suggest:
- Lobectomy dominated the market in 2016. Lobectomy procedure
involves removal of an entire lobe of the lung in cases of stage one
non–small cell lung cancer (NSCLC). It is preferred over the limited
resections as a large portion is removed, thereby decreasing the risk of
recurrence in the local area.
- There is a trend of increasing adoption of minimally invasive
technique in other types of thoracic surgery such as sleeve lobectomy,
segmentectomy, and thoracic sympathectomy. The factors owing to the growth
is the technological advancements, better imaging technologies and the
introduction of minimally invasive surgical devices.
- Geographically, North America held the largest market share in 2016
and is expected to maintain its position during the forecast period. This
region dominated the market on account of the high prevalence of the
target disorder, high smoking traits in the population and the huge
funding involved in the research involving solutions to lung cancer.
- Moreover, availability of the technologically advanced surgical
methods with better surgeon expertise is expected to increase the market
growth.
- Asia-Pacific region shows the fastest growth in the coming years
due to rapid adoption of technology and growing awareness about the target
disorders
- Some key industry contributors are Medtronic plc, Cardio medical
GmbH, Intuitive Surgical, Richard Wolf GmbH, Grena Ltd., Dextera Surgical
Inc., Teleflex Incorporated, Medela Healthcare, LivaNova plc, Sklar
Surgical Instruments.
Browse more reports of this category
by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the minimally invasive thoracic surgery market by
type and region:
Type
Outlook (Market Revenue in USD Million, 2014 - 2025)
- Lobectomy
- Wedge
Resection
- Pneumonectomy
- Others
Regional
Outlook (Market Revenue in USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- Middle East
and Africa
- South Africa
About Grand View
Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment